Closed
SectorHealthcare
591.21 3.55
24h
Min
569.59
Max
596.21
Income | 583M 1.4B |
---|---|
Sales | 647M 3.7B |
P/E Sector Avg | 14.471 35.473 |
EPS | 8.22 |
Dividend yield | 0.3 |
Profit margin | 37.86 |
Employees | 15,182 |
EBITDA | 617M 1.7B |
Recommendations | Buy |
---|---|
12 Months Forecast | +26.29% upside |
Dividend yield Sector Avg | 0.30% 2.38% |
---|---|
Next Earnings | 30 paź 2025 |
Market Cap | 515M 61B |
---|---|
Previous open | 587.66 |
Previous close | 591.21 |
By Acuity
32%
68%
104 / 373 Ranking in Healthcare
By Trading Central
Confidence
Very Strong Bearish Evidence
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Price change
By TipRanks
12 Months Forecast
Average 722.09 USD 26.29%
High 890 USD
Low 543 USD
Based on 25 Wall Street analysts offering 12 month price targets forRegeneron Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Bullish Evidence
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$